Gene · 192343
Papers2,533
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,533
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A desert lncRNA HIDEN regulates human endoderm differentiation via interacting with IMP1 and stabilizing FZD5 mRNA. | Genome Biol | 2023 | 37095549 | PubTator, text mining | PubMed |
| MiR-199a-5P promotes osteogenic differentiation of human stem cells from apical papilla via targeting IFIT2 in apical periodontitis. | Front Immunol | 2023 | 37063854 | PubTator, text mining | PubMed |
| LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing SOX2 expression. | Int J Biol Sci | 2023 | 37063420 | PubTator, text mining | PubMed |
| LncRNA RP11-620J15.3 promotes HCC cell proliferation and metastasis by targeting miR-326/GPI to enhance glycolysis. | Biol Direct | 2023 | 37020316 | PubTator, text mining | PubMed |
| Hsa_circ_0008500 inhibits apoptosis of adipose-derived stem cells under high glucose through hsa-miR-1273h-5p/ELK1 axis. | Environ Toxicol | 2023 | 37014014 | PubTator, text mining | PubMed |
| Hsa_circ_0001535 inhibits the proliferation and migration of ovarian cancer by sponging miR-593-3p, upregulating PTEN expression. | Clin Transl Oncol | 2023 | 37000289 | PubTator, text mining | PubMed |
| A novel lncRNA 495810 promotes the aerobic glycolysis in colorectal cancer by stabilizing pyruvate kinase isozyme M2. | Int J Oncol | 2023 | 36960860 | PubTator, text mining | PubMed |
| Circular RNA circHMCU promotes breast tumorigenesis through miR-4458/PGK1 regulatory cascade. | Hereditas | 2023 | 36949536 | PubTator, text mining | PubMed |
| LncRNA ENST00000370438 promotes cell proliferation by upregulating DHCR24 in breast cancer. | Mol Carcinog | 2023 | 36946578 | PubTator, text mining | PubMed |
| Erythrocyte miRNA-92a-3p interactions with PfEMP1 as determinants of clinical malaria. | Funct Integr Genomics | 2023 | 36941394 | PubTator, text mining | PubMed |
| Effects of miR-9-5p on the migration, invasion and epithelial-mesenchymal transition process in cervical squamous cell carcinoma. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2023 | 36935173 | PubTator, text mining | PubMed |
| The hsa_circ_0000276-ceRNA regulatory network and immune infiltration in cervical cancer. | BMC Cancer | 2023 | 36894874 | PubTator, text mining | PubMed |
| CircAGO2 promotes colorectal cancer progression by inhibiting heat shock protein family B (small) member 8 via miR-1-3p/retinoblastoma binding protein 4 axis. | Funct Integr Genomics | 2023 | 36881338 | PubTator, text mining | PubMed |
| CIRC_0012535 CONTRIBUTES TO LIPOPOLYSACCHARIDE-INDUCED FETAL LUNG FIBROBLAST APOPTOSIS AND INFLAMMATION TO REGULATE INFANTILE PNEUMONIA DEVELOPMENT BY MODULATING THE MIR-338-3P/IL6R SIGNALING. | Shock | 2023 | 36870073 | PubTator, text mining | PubMed |
| LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer. | Mol Cancer | 2023 | 36859185 | PubTator, text mining | PubMed |
| The MYC-regulated lncRNA LNROP (ENSG00000254887) enables MYC-driven cell proliferation by controlling the expression of OCT2. | Cell Death Dis | 2023 | 36849510 | PubTator, text mining | PubMed |
| Lnc-AIFM2-1 promotes HBV immune escape by acting as a ceRNA for miR-330-3p to regulate CD244 expression. | Front Immunol | 2023 | 36845111 | PubTator, text mining | PubMed |
| LncRNA15691 promotes T-ALL infiltration by upregulating CCR9 via increased MATR3 stability. | J Leukoc Biol | 2023 | 36822174 | PubTator, text mining | PubMed |
| Inhibition of miR-101-3p prevents human aortic valve interstitial cell calcification through regulation of CDH11/SOX9 expression. | Mol Med | 2023 | 36809926 | PubTator, text mining | PubMed |
| Screening and identification of miR-181a-5p in oral squamous cell carcinoma and functional verification in vivo and in vitro. | BMC Cancer | 2023 | 36800936 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/192343/papers?page=2